Letter by Dai et al Regarding Article, "Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial".
Letter by Dai et al Regarding Article, "Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial".
Dai, Tian + 1 more
Abstract ↗AI briefThe abstract is read at the publisher; the brief is JClub's.
The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.